| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 112 |
| 1 | TREPROSTINIL | 111 |
| 2 | MACITENTAN | 103 |
| 3 | SILDENAFIL CITRATE | 95 |
| 4 | TADALAFIL | 79 |
| 5 | SILDENAFIL | 78 |
| 6 | AMBRISENTAN | 51 |
| 7 | FOSCARBIDOPA/FOSLEVODOPA | 47 |
| 8 | APIXABAN | 42 |
| 9 | FUROSEMIDE | 41 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 112 | 0.0085 |
| 1 | FOSCARBIDOPA/FOSLEVODOPA | 47 | 0.0053 |
| 2 | MACITENTAN | 103 | 0.0015 |
| 3 | ENTACAPONE | 6 | 0.0014 |
| 4 | KETAMINE HYDROCHLORIDE | 7 | 0.0014 |
| 5 | SOTATERCEPT-CSRK | 6 | 0.0010 |
| 6 | ERGOCALCIFEROL | 27 | 0.0009 |
| 7 | MIDODRINE HYDROCHLORIDE | 4 | 0.0009 |
| 8 | TREPROSTINIL | 111 | 0.0009 |
| 9 | TADALAFIL | 79 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 205 |
| 1 | Endothelin Receptor Antagonist [EPC] | 148 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 95 |
| 3 | Loop Diuretic [EPC] | 51 |
| 4 | Osmotic Laxative [EPC] | 38 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 32 |
| 6 | Aldosterone Antagonist [EPC] | 27 |
| 7 | Corticosteroid [EPC] | 26 |
| 8 | Soluble Guanylate Cyclase Stimulator [EPC] | 25 |
| 9 | Potassium Salt [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 205 | 0.0015 |
| 1 | Catechol-O-Methyltransferase Inhibitor [EPC] | 7 | 0.0014 |
| 2 | Endothelin Receptor Antagonist [EPC] | 148 | 0.0007 |
| 3 | Soluble Guanylate Cyclase Stimulator [EPC] | 25 | 0.0007 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 95 | 0.0007 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 16 | 0.0006 |
| 6 | Antisense Oligonucleotide [EPC] | 4 | 0.0003 |
| 7 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 9 | 0.0003 |
| 8 | Aromatic Amino Acid [EPC] | 17 | 0.0003 |
| 9 | Barbiturate [EPC] | 3 | 0.0003 |